PT Siloam International Hospitals (SILO) Q4 2024 earnings summary

Executive summary

• Revenue increased to Rp12,207,563 million in 2024, up from Rp11,190,511 million in 2023, driven by both inpatient and outpatient services.

• Net income attributable to owners was Rp902,152 million, down from Rp1,211,283 million year-over-year.

• Gross profit rose to Rp4,862,032 million from Rp4,455,222 million, but operating profit declined to Rp1,426,643 million from Rp1,728,285 million.

• Total assets reached Rp14,206,336 million, up from Rp10,982,062 million, reflecting significant capital investments.

Financial highlights

• Revenue grew 9.1% year-over-year, with inpatient and outpatient segments both contributing.

• Net income decreased 25.5% year-over-year, mainly due to higher operating and other expenses.

• Earnings per share (EPS) dropped to Rp69.49 from Rp93.27 year-over-year.

• Total equity increased to Rp8,751,628 million from Rp8,047,636 million.

• Cash and cash equivalents at year-end were Rp2,101,314 million, up from Rp1,186,238 million.

Outlook and guidance

• Management continues to focus on expanding hospital operations and investing in new facilities.

• Capital expenditures are projected to support ongoing construction and equipment upgrades.